早期肝纤维化药物治疗的现状及展望

沈雁冰; 郑纯梅

早期肝纤维化药物治疗的现状及展望

1. 三峡大学第一临床医学院宜昌市中心医院

详细信息

中图分类号: R575.2
计量
- 文章访问数: 3202
- HTML全文浏览量: 11
- PDF下载量: 909
- 被引次数: 0
出版历程
- 出版日期: 2008-01-20

摘要

HTML全文

参考文献(21)

[1]赵景民, 周光德, 李文淑, 等.复方鳖甲软肝片抗肝纤维化机制的实验研究[J].解放军医学杂志, 2004, 29 (7) ∶560.

[2]Iredale JP, Benyon RC, Pickering J, et al.Mechanisms of spontane-ous resolation of rat liver fibrosis Hepatic stellate cell apotosis andVeduced hepafic expression of metalloproteinose innibitors[J].J ClinInvest, 1998, 102∶538-549.

[3]宋东眷, 刘平.星状细胞在肝纤维化中的作用[J].肝脏, 2000, 5∶157.

[4]姜藻, 尤大钰.16, 16一二甲基PGE, 秋水仙碱和硫酸锌抗肝纤维化的实验研究[J].中华消化杂志, 1994, 14 (3) ∶153.

[5] 顾长海, 曹锐, 汪耕祥, 等.PGE对肝细胞的保护作用和早期重症肝炎的价值[J].中华内科杂志, 1991, 30 (1) ∶17.

[6]Chen X, Li M, Le X, et al.Recombinath hepatitis B Core antigencanying pres, epitopes induce immune respose agaimst chronic HBVinfection[J].Vaccine, 2004, 22∶439-446.

[7]郭永红, 郝志明, 罗金燕, 等.重组转化生长因子β1疫苗诱导产生抗体的活性检测及抗肝纤维化的作用[J].中华肝脏病杂志, 2006, 3∶183-186.

[8]Paoaky riakou P, Tzardi M, Valatas V, et al.Apoptosis and apopto-sis related proteius in chronic riral liver disease[J].Apoptosis, 2002, 7∶133-141.

[9]范建高, 邵燕, 洪健.TGF-β、TIMPα及中性脂质队L-02细胞生物活性影响[J].中华肝脏病杂志, 2002, 10∶388-389.

[10]刘梁英, 李孝生, 万晓强.川芎嗪和大黄酸对肝细胞增殖和凋亡的影响[J].中华肝脏病杂志, 2006, 3∶219-221.

[11]UeKi T, Kaneda Y, Tsutui H, et al.Hepatocyte growth factor genetherapy of liver cinhosis in rats[J].Nat Med, 1999, 5∶226-230.

[12]Burt A, Path M, Bail B, et al.Morphologic investigaton of sinusoi-dallells[J].Semin Liver Dis.1993, 13 (1) ∶21-38.

[13]王宝恩.肝星状细胞与肝纤维化[J].中华肝脏病杂志, 2000, 8∶197-198.

[14]Benyon RC, Arthur MJ.Extracellular matrix degradation and therole of hepatic stellate cells[J].Semin Liver Dis, 2001, 21∶373-384.

[15]Nie QH, Cheng YQ, Xie YM, et al.Inhibiting effect of autisenseoligonucle otides phosphorthioate on gene expression of TIMP-lin ratliver fibrosis[J].Wold J Gastroenterol, 2001, 7∶363-369.

[16]Garciar Banuelos J, Siller-Lopez F, Miranda A, et al Cirrhotic ratlivers with extensive fibrosis can be safely transdued whit clinicat-grade adenviral vectors[J].Evidence of cirrhosis reversion Gene T-her, 2002, 9∶127-134.

[17]Zhang LH, Pan JP, Yao HP, et al, Intrasplenic trans plantation ofIL-18geme-mvdified hepatocy:aneffective approach to reverse he-patic fibrsis in schistosomiasis through induction of dominant Th1 re-sponse[J].GenpTher 2001, 8∶1333-1342.

[18]Rudolph KL, Chang S, Millard M, et al.Inhibition of experimentalliver cirrhosis in mice by telomerase gene delivery[J].science, 2000, 287∶1253-1258.

[19] 蔡卫民.肝硬化研究的某些进展[J].肝病与胃肠病学杂志, 1992, 1 (1) ∶11-17.

[20] 王要军, 孙自勤, 权启镇, 等.汉房己甲素治疗大鼠实验性肝纤维化的研究[J].临床肝胆病杂志, 1993, 9∶40-41.

[21]王继明, 倪世秋.络病用药规律处探[J].中国中医基础医学杂志, 2001, 7 (3) ∶56.

施引文献

资源附件(0)

访问统计